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Up-regulation of mitochondrial antioxidant superoxide dismutase
underpins persistent cardiac nutritional-preconditioning by long chain n-3
polyunsaturated fatty acids in the rat
Abstract
Reactive oxygen species paradoxically underpin both ischaemia/reperfusion (I/R) damage and ischaemic
preconditioning (IPC) cardioprotection. Long-chain omega-3 polyunsaturated fatty acids (LCn-3 PUFA) are
highly susceptible to peroxidation, but are paradoxically cardioprotective. This study tested the hypothesis
that LCn-3 PUFA cardioprotection is underpinned by peroxidation, upregulating antioxidant activity to
reduce I/R-induced lipid oxidation, and the mechanisms of this nutritional preconditioning contrast to
mechanisms of IPC. Rats were fed: fish oil (LCn-3 PUFA); sunflower seed oil (n-6 PUFA); or beef tallow
(saturated fat, SF) enriched diets for six weeks. Isolated hearts were subject to: 180 min normoxic perfusion; a
30 min coronary occlusion ischaemia protocol then 120 min normoxic reperfusion; or a 3 x 5 min global IPC
protocol, 30 min ischaemia, then reperfusion. Dietary LCn-3 PUFA raised basal: membrane docosahexaenoic
acid (22:6n-3 DHA); fatty acid peroxidisability index; concentrations of lipid oxidation products; and
superoxide dismutase (MnSOD) activity (but not CuZnSOD or glutathione peroxidase). Infarct size
correlated inversely with basal MnSOD activity (r2 = 0.85) in the ischaemia protocol and positively with I/R-
induced lipid oxidation (lipid hydroperoxides (LPO), r2 = 0.475; malondialdehyde (MDA), r2 = 0.583)
across ischaemia and IPC protocols. While both dietary fish oil and IPC infarct-reduction were associated
with reduced I/R-induced lipid oxidation, fish oil produced nutritional preconditioning by prior LCn-3 PUFA
incorporation and increased peroxidisability leading to up-regulated mitochondrial SOD antioxidant activity.
Publication Details
Abdukeyum, G. G., Owen, A. J., Larkin, T. A. & McLennan, P. L. (2016). Up-regulation of mitochondrial
antioxidant superoxide dismutase underpins persistent cardiac nutritional-preconditioning by long chain n-3
polyunsaturated fatty acids in the rat. Journal of Clinical Medicine, 5 (3), 32-1-32-13.




Up-Regulation of Mitochondrial Antioxidant
Superoxide Dismutase Underpins Persistent Cardiac
Nutritional-Preconditioning by Long Chain n-3
Polyunsaturated Fatty Acids in the Rat
Grace G. Abdukeyum 1, Alice J. Owen 2, Theresa A. Larkin 3 and Peter L. McLennan 3,*
1 Division of Medical and Exercise Science, School of Medicine, Faculty of Science Medicine and Health,
University of Wollongong, Wollongong NSW 2522, Australia; Grace.Abdukeyum@hnehealth.nsw.gov.au
2 Centre of Cardiovascular Research & Education in Therapeutics, School of Public Health & Preventive
Medicine, Monash University, Melbourne VIC 3004, Australia; alice.owen@monash.edu
3 Centre for Human and Applied Physiology, Graduate School of Medicine, School of Medicine,
Faculty of Science Medicine and Health, University of Wollongong, Wollongong NSW 2522, Australia;
tlarkin@uow.edu.au
* Correspondence: petermcl@uow.edu.au; Tel.: +61-2-4221-4183; Fax: +61-2-4221-4341
Academic Editors: Lindsay Brown, Bernhard Rauch and Hemant Poudyal
Received: 16 November 2015; Accepted: 29 February 2016; Published: 4 March 2016
Abstract: Reactive oxygen species paradoxically underpin both ischaemia/reperfusion (I/R) damage
and ischaemic preconditioning (IPC) cardioprotection. Long-chain omega-3 polyunsaturated fatty
acids (LCn-3 PUFA) are highly susceptible to peroxidation, but are paradoxically cardioprotective.
This study tested the hypothesis that LCn-3 PUFA cardioprotection is underpinned by peroxidation,
upregulating antioxidant activity to reduce I/R-induced lipid oxidation, and the mechanisms of this
nutritional preconditioning contrast to mechanisms of IPC. Rats were fed: fish oil (LCn-3 PUFA);
sunflower seed oil (n-6 PUFA); or beef tallow (saturated fat, SF) enriched diets for six weeks. Isolated
hearts were subject to: 180 min normoxic perfusion; a 30 min coronary occlusion ischaemia protocol
then 120 min normoxic reperfusion; or a 3 ˆ 5 min global IPC protocol, 30 min ischaemia, then
reperfusion. Dietary LCn-3 PUFA raised basal: membrane docosahexaenoic acid (22:6n-3 DHA); fatty
acid peroxidisability index; concentrations of lipid oxidation products; and superoxide dismutase
(MnSOD) activity (but not CuZnSOD or glutathione peroxidase). Infarct size correlated inversely
with basal MnSOD activity (r2 = 0.85) in the ischaemia protocol and positively with I/R-induced
lipid oxidation (lipid hydroperoxides (LPO), r2 = 0.475; malondialdehyde (MDA), r2 = 0.583) across
ischaemia and IPC protocols. While both dietary fish oil and IPC infarct-reduction were associated
with reduced I/R-induced lipid oxidation, fish oil produced nutritional preconditioning by prior
LCn-3 PUFA incorporation and increased peroxidisability leading to up-regulated mitochondrial
SOD antioxidant activity.
Keywords: fish oil; preconditioning; antioxidant; reactive oxygen species; ischaemia; reperfusion;
n-3 PUFA; lipid oxidation; infarct
1. Introduction
Regular consumption of fish or fish oil reduces cardiovascular mortality [1], often without
modifying classical risk factors. For example, sudden death is reduced in high-risk post-MI patients,
without significant reductions in blood pressure, blood lipids or prevention of new cardiac events [2].
This cardioprotection, associated with omega-3 long-chain polyunsaturated fatty acid (LCn-3 PUFA)
consumption, is observed independently of the prevention of ischaemic events [3], and therefore
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supports a cardiac origin related to incorporation of the fatty acids into myocardial membranes [4].
Ischaemic preconditioning (IPC) is a powerful cardioprotective process, wherein brief periods of
ischaemia, insufficient to produce cellular damage, can protect the myocardium from the damaging
effects of a subsequent more prolonged ischaemic insult. The protective envelope of IPC is twofold,
categorised as: classical or early preconditioning, which provides cardioprotection for several hours
after the IPC stimulus; with a second phase called late or delayed preconditioning which occurs 24–7 h
after the stimulus. Experimentally, the LCn-3 PUFA confer their cardioprotection in part through
nutritional preconditioning of the myocardium that in rat heart is at least as effective in reducing infarct
size [5,6] and promoting post-ischaemic contractile recovery [5], and more effective in preventing
ischaemia or reperfusion induced cardiac arrhythmias [5], as early ischaemic preconditioning (IPC).
Classical, early IPC cardioprotection disappears within several hours of the initial preconditioning
stimulus and repeated brief preconditioning episodes become ineffective in providing this early
protection [7]. In contrast, the cardioprotection derived from dietary LCn-3 PUFA is obtained only
after they are incorporated into and continuously present in the myocardium for at least seven days
and it persists over weeks or months, for however long elevated membrane content is sustained [5,8,9].
There is no desensitisation apparent, with acute ischaemia or reperfusion arrhythmias prevented
after five weeks [8] to 52 weeks [10] of continuous exposure to dietary LCn-3 PUFA. Therefore, the
cardioprotective benefit of fish oil appears to mimic the more sustained, repeatable protection of late
IPC and other persistent preconditioning stimuli [11–13]. Moreover, the LCn-3 PUFA [5] share with
late IPC [14] the capacity to protect against both infarction and myocardial stunning.
Myocardial ischaemia and reperfusion (I/R) stimulates production of reactive oxygen species
(ROS) and depletes antioxidants in the heart, creating oxidative stress, oxidation of biomolecules and
cell damage. Paradoxically, these free radicals also act as triggers of IPC [15,16]. The highly unsaturated
LCn-3 PUFA found in fish oil: 20:5n-3 eicosapentaenoic acid (EPA) and 22:6n-3 docosahexaenoic
acid (DHA) with their numerous bisallylic carbon atoms, are more susceptible to peroxidation and
generation of damaging reactive oxygen species than are shorter, less unsaturated fatty acids such as
18:2n-6 linoleic acid and 20:4n-6 arachidonic acid [17], which raises the prospect of adverse effects of
fish oil supplementation. However, there is no clinical evidence to suggest that fish oil supplementation
or high fish diets promote oxidative stress-related cardiovascular disease. In contrast, production of
ROS is a mechanism invoked to explain the paradoxical effects of late IPC in the heart, which works
by inducing upregulation of endogenous antioxidant protective mechanisms [16,18]. That protection
occurs in lieu of the extreme oxidation of biomolecules and cell damage that usually occurs with
I/R-induced oxidative stress and antioxidant depletion.
The current study tested the hypothesis that incorporation of LCn-3 PUFA into myocardial
membranes increases their peroxidation potential and basal fatty acid oxidation, which by their
constant presence, in turn increases endogenous antioxidant enzymes to confer physiological
cardioprotective actions against I/R-stimulated oxidative stress. We propose that this will contrast to
the mechanism of early IPC cardioprotection.
2. Experimental Section
2.1. Animals and Diets
Fifty-four male Wistar rats were randomly assigned to three experimental dietary groups.
For six weeks they were fed one of three iso-energetic diets containing either predominantly saturated
animal fat, n-6 PUFA or LCn-3 PUFA as the source of fat. The diets were based on the American
Institute of Nutrition AIN93 rat diet, containing all essential vitamins and minerals with gelatine as a
component of the protein source. The diet was prepared with 10% (dry wt) fat (23% metabolisable
energy as fat) consisting of: 7% beef tallow plus 3% olive oil (SF diet); 5% sunflower seed oil plus
5% olive oil (n-6 PUFA diet); or 7% fish oil (Nu-Mega high DHA tuna fish oil) plus 3% olive oil
(LCn-3 PUFA diet). In addition to delivering diets rich in saturated fat, n-6 PUFA or n-3 PUFA, the oil
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blends in the LCn-3 PUFA diet and the n-6 PUFA diet were designed to deliver similar total PUFA,
and the oil blends in the LCn-3 PUFA diet and the SF diet were designed to deliver similar total n-6
PUFA, as previously described [5]. All diets contained sufficient PUFA to prevent essential fatty acid
deficiency [5].
Animal care and experiments were conducted with the approval of the University of Wollongong,
Animal Care and Ethics Committee according to the guidelines of the National Health and Medical
Research Council, Australia, Australian Code of Practice for the Care and Use of Animals for Scientific
Purposes [19].
2.2. Heart Preparation
After six weeks of feeding, rats were anaesthetised (pentobarbital sodium, 60 mg¨kg´1 i.p.),
the thorax was opened, the heart was rapidly excised, submerged in ice-cold perfusate to arrest
beating, and immediately perfused by an aortic cannula in the Langendorff mode at a constant
pressure of 75 mmHg delivering warm (37 ˝C) Krebs–Henseleit bicarbonate buffer gassed with 5%
CO2 in O2 [5]. The left atrium was opened and a thin-walled balloon catheter was introduced into the
left ventricle, with balloon volume adjusted to maintain end diastolic pressure of 6–8 mmHg. 6–0 silk
suture was passed through the myocardium closely underlying the left anterior descending coronary
artery near its origin.
2.3. Index Ischaemia and Ischaemic Preconditioning
Each dietary group (n = 18) was separated into groups of n = 6 and randomly assigned to one of
three perfusion protocols for 180 min after initial 30 min equilibration perfusion (Figure 1).
1. Control normoxia protocol (n = 6 per diet): Hearts were perfused throughout with oxygenated
Krebs–Henseleit solution.
2. Ischaemia protocol (n = 6 per diet): Hearts were normoxically perfused for 30 min followed by
30 min index-ischaemia and 120 min normoxic reperfusion. Index-ischaemia was induced by
occluding the left anterior descending coronary artery.
3. Ischaemic preconditioning (IPC) protocol (n = 6 per diet): Hearts were subjected to three cycles
of five minutes global ischaemia (zero perfusion), each followed by five minutes normoxic
reperfusion, prior to the 30 min index-ischaemia then 120 min normoxic reperfusion [5].
On completion of 120 min reperfusion in the ischaemia and IPC protocols, the coronary artery
was re-occluded to reveal the ischaemic zone at risk (I-z/r). Hearts were then cut into 2 mm slices.
The central slice was incubated in a buffer containing triphenyl-tetrazolium chloride and sodium
phosphate (pH 7.4), then stored in 10% formalin until photographed and analysed for infarct size.
Infarct size was reported as a percentage of the zone at risk. The remaining slices were separated into
non-ischaemic (non-I) and ischaemic (ISCH) segments (Figure 1). Samples of fresh ISCH and non-I
tissue were used immediately for lipid hydroperoxide (LPO) analysis, with the remainder rapidly
frozen and stored at ´80 ˝C for analysis of other markers of oxidation and antioxidant status. Samples
of control normoxic heart were always taken from the left ventricle anterior free wall, supplied by
the left anterior descending coronary artery, that would have been subject to ischaemia in the other
protocols. It represents the basal state of the ischaemic zone at risk.
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Figure 1. Flow chart illustrating the distribution of dietary groups into: Control normoxic; Ischaemia;
and IPC perfusion protocols. In each protocol, isolated hearts were perfused for 180 min. Ischaemia
protocol and IPC protocol hearts were dissected into non-ischaemic (non-I) and ischaemic (ISCH) tissue
for biochemical analysis. IPC: ischaemic preconditioning.
2.4. Measurement of Oxidative Stress Biomarkers
Concentrations of LPO were measured by modification of the ferric thiocyanate assay using a
colorimetric assay kit (Lipid Hydroperoxide Assay, Cayman Chemical Company, Ann Arbor, MI, USA)
and were expressed per mg of protein. Concentrations of malondialdehyde (MDA) were measured in
thawed tissue homogenates by reverse-phase HPLC with fluorescence detection [20].
2.5. Measurement of Antioxidants
Endogenous: Total superoxide dismutase (SOD) activity and CuZnSOD activity were measured
in ventricle sections of: ISCH tissue; and non-I tissue using a BIOXYTECH®-SOD-525™ assay kit
(Oxis Research™, Portland, OR, USA). The activity of mitochondrial SOD activated by manganese
(MnSOD) was calculated as the difference between total SOD and CuZnSOD. The activity of SOD was
expressed per mg of tissue protein. Glutathione peroxidase (GPX) activity was measured in ventricle
sections of: ISCH; and non-I ventricle using BIOXYTECH®GPx-340TM assay kit (OxisResearch™,
Portland OR, USA) and was expressed per mg of tissue protein. Exogenous: Myocardial vitamin E
(alpha-tocopherol) was measured by HPLC with electrochemical detection, using a modification of the
method described by Yang [21].
2.6. Myocardial Fatty Acid Analyses
Total lipids were extracted from 100 to 200 mg samples of ventricular myocardium using a
modification of the Folch method [22]. Phospholipids were isolated from the total muscle lipid
by solid phase extraction using silica Sep-pak™ cartridges (Waters, Rydalmere, NSW, Australia).
Fatty acid methyl esters were prepared by direct transesterification of the phospholipid fraction [23]
and analysed by gas chromatography using a Shimadzu GC-17A with flame ionization detection
using a 30 m ˆ 0.25 mm, 0.25 µm FAMEWAX column (J and W Scientific, Santa Clara CA, USA) with
hydrogen as carrier gas and a step temperature program rising from 150 ˝C to 260 ˝C, over 27 min
and held for 6 min. Individual fatty acids were identified by their retention times with reference to
authentic fatty acid methyl ester standards (Sigma-Aldrich, Rydalmere, NSW, Australia) and expressed
as a percentage of total phospholipid fatty acids.
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2.7. Statistical Analyses
Results were expressed as mean ˘ SEM. Data were analysed by two-way analysis of variance
(ANOVA) for diet and treatment main effects (normoxic perfusion, ischaemia, IPC + ischaemia)
and by multi-way ANOVA for diet, treatment and ISCH versus non-I tissue main effects. Tukey’s
HSD test was used for post-hoc pairwise comparison of individual means and interactions. Within
dietary groups, ISCH and non-I sections of the same hearts were compared using repeated measures
ANOVA. Statistical analyses were performed using Statistix software, version 10 (Analytical Software,
Tallahassee, FL, USA). Linear regression analysis with Pearson’s correlation was performed to
determine linear associations between lipid oxidation products, antioxidants and infarct size using
Prism for Windows, version 6 (GraphPad Software, La Jolla, CA, USA). Statistical significance was
accepted at p < 0.05.
3. Results
Neither the starting body weight, the final body weight nor the change in body weight over six
weeks differed between dietary groups (Start: SF 348˘ 6 g; n-6 PUFA 351˘ 5 g; LCn-3 PUFA 352 ˘ 6 g.
Six weeks: SF 460 ˘ 11 g; n-6 PUFA 457 ˘ 8 g; LCn-3 PUFA 480 ˘ 9 g. Change: SF 112 ˘ 7 g; n-6 PUFA
109 ˘ 9 g; LCn-3 PUFA 128 ˘ 7 g. n = 18 per diet).
3.1. Myocardial Membrane Phospholipid Fatty Acid Composition
The relative concentration of DHA (22:6n-3) was greater in phospholipid of LCn-3 PUFA hearts
than in either n-6 PUFA or SF hearts (p < 0.05) (Table 1). The LCn-3 PUFA hearts contained significantly
lower concentrations of linoleic (18:2n-6) and arachidonic acids (20:4n-6) compared with n-6 PUFA
or SF hearts. Total n-3 PUFA was greater in LCn-3 PUFA hearts compared with either n-6 PUFA or
SF hearts, and lower in n-6 PUFA than SF hearts (p < 0.05). The total concentration of n-6 PUFA was
lower in LCn-3 PUFA hearts than in either n-6 PUFA or SF hearts and greater in n-6 PUFA than SF
hearts (p < 0.05).
Table 1. Influence of dietary fat (six weeks) on phospholipid fatty acid composition as percentage of
total phospholipid fatty acids of rat heart ventricle.
DIET
Fatty Acid SF n-6 PUFA LCn-3 PUFA
16:0 9.7 ˘ 0.1 10.2 ˘ 0.2 10.8 ˘ 0.1
18:0 23.7 ˘ 0.2 23.8 ˘ 0.1 22.4 ˘ 0.2
18:1n-9 a 9.5 ˘ 0.1 b 5.4 ˘ 0.1 b 4.3 ˘ 0.3
18:1n-7 3.6 ˘ 0.1 3.5 ˘ 0.1 3.4 ˘ 0.1
Total SFA 33.80 ˘ 0.13 34.70 ˘ 0.80 33.70 ˘ 0.40
Total MUFA a 13.50 ˘ 0.12 b 8.95 ˘ 0.30 b 7.75 ˘ 1.10
18:2n-6 (LA) b 17.50 ˘ 0.20 a 18.7 ˘ 0.40 c 5.60 ˘ 0.03
20:4n-6 (AA) a 23.30 ˘ 0.30 a 23.5 ˘ 0.20 b 13.30 ˘ 0.15
22:5n-6 n.d a 1.50 ˘ 0.12 a 1.06 ˘ 0.05
20:5n-3 (EPA) n.d n.d 1.30 ˘ 0.01
22:5n-3 (DPA) 1.90 ˘ 0.04 1.02 ˘ 0.02 1.17 ˘ 0.04
22:6n-3 (DHA) b 12.20 ˘ 0.04 b 10.02 ˘ 0.20 a 28.30 ˘ 0.04
Total (n-6) PUFA b 40.80 ˘ 0.20 a 43.80 ˘ 0.60 c 20.00 ˘ 0.16
Total (n-3) PUFA b 14.10 ˘ 0.06 c 11.00 ˘ 0.20 a 30.70 ˘ 0.08
Total PUFA 54.90 ˘ 4.50 54.70 ˘ 4.50 50.70 ˘ 4.40
UI b 215.40 ˘ 1.20 b 215.10 ˘ 0.50 a 260.58 ˘ 1.20
Peroxidisability Index b 156.20 ˘ 1.20 b 149.50 ˘ 1.60 a 201.10 ˘ 0.70
SF: saturated fat enriched diet; n-6 PUFA: n-6 PUFA enriched diet; LCn-3 PUFA: n-3 PUFA enriched diet; SFA:
saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; LA: linoleic
acid; AA: arachidonic acid; EPA: eicosapentaenoic acid; DPA: docosahexaenoic acid; DHA: docosahexaenoic
acid. Unsaturation index (UI) was calculated according to the formula: UI = 1 ˆ (% monoenoic acids) + 2 ˆ
(% dienoics) + 3 ˆ (% trienoics) + 4 ˆ (% tetraenoics) + 5 ˆ (% pentaenoics) + 6 ˆ (% hexaenoics) or sum (fatty
acid percent) ˆ (number of double bonds). Peroxidatisability index was calculated from the formula: (% dienoic
acids ˆ 1) + (% trienoics ˆ 2) + (% tetraenoics ˆ 3) + (% pentaenoics ˆ 4) + (% hexaenoics ˆ 5) [17]. n.d: not
detected. n = 6 per dietary group. a, b, c Values not sharing a common letter superscript are significantly different
(ANOVA, p < 0.05).
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No significant dietary differences were observed in the membrane phospholipid total saturated
fatty acids or total PUFA. The SF hearts had greater concentrations of total monounsaturated fatty acids
(MUFA). Membrane unsaturation index (UI) and peroxidisability index (Figure 2A) were significantly
greater in LCn-3 PUFA than in either n-6 PUFA or SF hearts (p < 0.05), which were not significantly
different from each other.
J. Clin. Med. 2016, 5, 32  6 of 13 
 































hearts. The  concentrations of LPO and MDA  in  the  ISCH  region were  significantly greater  in SF 
hearts than in LCn‐3 PUFA hearts (Figure 3A,B). 
IPC:  There were  no  significant  acute  changes  in  LPO  or MDA  in  ISCH  compared  to  non‐I 
regions  within  any  dietary  group  (Figure  3A,B),  nor  were  there  any  significant  between‐diet 
differences within the ISCH regions of IPC + ischaemia hearts. Concentrations of LPO and MDA in 
ISCH regions were significantly lower in IPC + ischaemia hearts than in ischaemia only hearts (p < 
0.0001). Pairwise  comparison  indicated  that  this  IPC difference was evident  in SF and n‐6 PUFA 
diets only. 
Figure 2. Influence of six w eks dietary fat fe l: ( ) e brane fatty acid peroxid sability
index; and concentrations of (B) lipid hydroperoxides (LPO); (C) malondialdehyde (MDA); and
(D) antioxidant superoxide dismutase (MnSOD) of b sal or non-I regions f t heart after 180 min of
isolated perfusion protocol. Open colu ns (SF): saturated fat diet; shaded columns (n-6): n-6 PUFA
rich diet; filled columns (n-3): LCn-3 PUFA rich fish oil diet. Values are means ˘ SEM. n = 18 per
dietary group except peroxidisability index: n = 6. * different from both other diet groups, p < 0.05.
# different from SF group, p < 0.05.
3.2. Basal Properties: Effects of Diet on Oxidative Stress and Antioxidant Activity
The basal and non-I tissue derived from the three perfusion protocols exhibited no significant
between protocol differences in tissue concentrations of lipid oxidation products LPO or MDA or
anti-oxidants within any dietary group (pooled data shown in Figure 2). This establishes the non-I
measures as representative of the basal state of the ISCH region.
The concentrations of LPO in basal and non-I tissue were significantly greater in LCn-3 PUFA
than in either n-6 PUFA or SF hearts and greater in n-6 PUFA than SF hearts (p < 0.05) (Figure 3A).
The concentrations of MDA in basal and non-I tissue were significantly greater in LCn-3 PUFA than in
either n-6 PUFA or SF hearts (p < 0.05), which were not different from each other (Figure 3B).
The activity of MnSOD in basal and non-I tissue was significantly greater in LCn-3 PUFA hearts,
than in SF or n-6 PUFA hearts (Figure 3C). In basal and non-I tissue there were no significant dietary
differences in CuZnSOD activity (basal, non-I (U¨mg´1 protein): SF 15.3 ˘ 0.9; n-6 PUFA 16.9 ˘ 0.7;
LCn-3 PUFA 17.4 ˘ 0.6 n = 18) (p > 0.05) or GPX (basal, non-I (mU¨mg´1 protein): SF 19.2 ˘ 1.5; n-6
PUFA 19.7 ˘ 1.5; LCn-3 PUFA 21 ˘ 1.2 n = 15). The concentration of α-toco herol was significantly
greater in n-6 PUFA hearts than in either LCn-3 PUFA or SF hearts (p < 0.05) (basal, non-I (µM):
SF 6.1 ˘ 0.4; n-6 PUFA 6.9 ˘ 0.2; LCn-3 PUFA 5.9 ˘ 0.6 n = 15).
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Figure 3. Influence of six weeks dietary fat feeding on cardiac lipid oxidation and antioxidant markers in
ischaemic (ISCH) or non-ischaemic (non-I) regions after: Control normoxic perfusion (basal), Ischaemia
perfusion, or ischaemic preconditioning (IPC) perfusion protocols: (A) lipid hydroperoxides (LPO);
(B) malondialdehyde (MDA); and (C) superoxide dismutase (MnSOD). Data are from hearts that
were normoxic throughout (basal), or the non-I and ISCH regions of hearts subjected to 30 min of
regional ischaemia with or without prior IPC. Diet groups: NN∆—saturated fat (SF); ˝—n-6 PUFA;
#—LCn-3 PUFA. Values are means ˘ SEM. n = 18 per diet, n = 6 per perfusion protocol. * ISCH
different from non-I region within diet, p < 0.05; # n-3 PUFA different from SF p < 0.05; † LCn-3 PUFA
and n-6 PUFA different from SF.
3.3. Ischaemic Responses: Effects of Diet and Ischaemic Preconditioning on Oxidative Stress and Antioxidant
Capacity in Hearts Subjected to Regional I/R
Ischaemia: The concentrations of LPO (Figure 3A) and MDA (Figure 3B) were acutely increased in
the ISCH comp red to non-I region of n-6 PUFA and SF hearts (p < 0.01) but not in LCn-3 PUFA hearts.
The concentrations of LPO and MDA in the ISCH region were significantly greater in SF hearts than in
LCn-3 PUFA hearts (Figure 3A,B).
IPC: There were no significant acute changes in LPO or MDA in ISCH compared to non-I regions
within any dietary group (Figure 3A,B), nor were there any significant between-diet differences within
the ISCH regions of IPC + ischaemia hearts. Concentrations of LPO and MDA in ISCH regions were
significantly lower in IPC + ischaemia hearts than in ischaemia only hearts (p < 0.0001). Pairwise
comparison indicated that this IPC difference was evident in SF and n-6 PUFA diets only.
Myocardial MnSOD activity was significantly greater in ISCH compared to non-I regions of hearts
from SF and n-6 PUFA fed rats but not significantly changed within LCn-3 PUFA hearts (Figure 3C).
The perfusion protocol incorporating IPC + ischaemia had no different effect on MnSOD activity to
ischaemia alone.
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3.4. Infarct
In hearts subjected to the ischaemia perfusion protocol, infarct size was significantly smaller in
LCn-3 PUFA hearts (ischaemia infarct size (% Iz/r): SF 50 ˘ 1 n = 6; n-6 PUFA 47 ˘ 1 n = 6; LCn-3
PUFA n = 6 11 ˘ 1 n = 6, (p < 0.05)). In hearts subjected to the IPC + ischaemia protocol, the infarct size
was significantly smaller in the SF and n-6 PUFA hearts than in the corresponding ischaemia group
(p < 0.05). There was no significant difference within the LCn-3 PUFA diet. (IPC + ischaemia infarct
size (% Iz/r): SF 13 ˘ 1 n = 6; n-6 PUFA 12 ˘ 1 n = 6; LCn-3 PUFA 10 ˘ 1 n = 6).
3.5. Associations between Oxidation Biomarkers, Antioxidant and Infarct Size
Ischaemia protocol: Infarct size was positively associated with lipid oxidation biomarker production
in the ISCH region, independent of diet (Table 2). The acute increases in LPO and MDA (ISCH
compared to the non-I region) correlated better than the absolute ISCH concentrations of LPO and
MDA. Lipid oxidation biomarkers LPO and MDA were correlated in the ISCH region. Ischaemic
production of LPO and MDA and infarct size were inversely associated with the basal (non-I) MnSOD
activity (Table 2). The strongest association was the inverse correlation between basal MnSOD and
infarct size (Figure 4).
IPC: In hearts subjected to the IPC + ischaemia perfusion protocol, infarct size was not significantly
correlated with LPO, MDA or MnSOD concentrations, and ischaemia-induced increase in MDA but not
LPO was correlated with MnSOD activity. Lipid oxidation biomarkers LPO and MDA were correlated
in the ISCH region (Table 2).
Pooled analysis of data from both perfusion protocols revealed significant correlations of infarct
size with lipid oxidation markers and with MnSOD. Lipid oxidation biomarkers LPO and MDA were
correlated in the ISCH region (Table 2).
Table 2. Correlations between lipid oxidation products, antioxidants and infarct size.
Dependent Variable Independent Variable Association r2 p for Slope
Ischaemia Protocol
Infarct LPO (ISCH) positive 0.337 * 0.018
Infarct LPO increase positive 0.478 ** 0.004
Infarct MDA (ISCH) positive 0.356 * 0.015
Infarct MDA increase positive 0.517 ** 0.004
Infarct MnSOD (basal) negative 0.851 ** <0.0001
MDA (ISCH) LPO (ISCH) positive 0.481 ** 0.006
LPO increase MnSOD (basal) negative 0.397 ** 0.009
MDA increase MnSOD (basal) negative 0.617 ** 0.001
IPC + Ischaemia Protocol
Infarct LPO (ISCH) positive 0.039 0.483 n.s.
Infarct LPO increase positive 0.147 0.175 n.s.
Infarct MDA (ISCH) positive 0.175 0.150 n.s.
Infarct MDA increase positive 0.009 0.728 n.s.
Infarct MnSOD (basal) negative 0.058 0.335 n.s.
MDA (ISCH) LPO (ISCH) positive 0.764 ** <0.0001
LPO increase MnSOD (basal) negative 0.128 0.174 n.s.
MDA increase MnSOD (basal) negative 0.293 * 0.017
Overall
Infarct LPO increase positive 0.583 ** <0.0001
Infarct MDA increase positive 0.475 ** <0.0001
Infarct MnSOD (basal) negative 0.270 * 0.0012
MDA (ISCH) LPO (ISCH) positive 0.760 ** <0.0001
LPO: lipid hydroperoxides. MDA: malondialdehyde. MnSOD: manganese superoxide dismutase. ISCH:
ischaemic region. Basal: non-ischaemic region of ventricle wall. n.s.: not significant (p > 0.05); * p < 0.05;
** p < 0.01.
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4. Discussion
A diet rich in LCn-3 PUFA from fish oil modified the fatty acid profile of myocardial membrane
phospholipids, increasing the percentage of fat as DHA and the peroxidisability index (predicting
an increase in risk of oxidative damage), yet paradoxically reduced the measured oxidative damage
following I/R. While the increased myocardial peroxidation potential was associated with an increase
in basal fatty acid peroxidation, confirming effects of DHA feeding recorded in plasma and liver [24],
it also induced a marked chronic increase in MnSOD (endogenous antioxidant) activity, and inhibited
I/R-induced lipid oxidation and infarction. Reactive oxygen species act as both the agents of damage
and of conservation in IPC, causing cellular damage yet triggering protective signalling processes [25].
In this respect, LCn-3 PUFA supplementation reflects both the low level generation of ROS through
lipid peroxidation [26] and up-regulation of endogenous antioxidants that are implicated as triggers
and mediators respectively of late phase IPC [27]. This aligns fish oil nutritional preconditioning [5]
not only with this more persistent form of IPC (variously known as late, delayed or second window
of IPC), but through LCn-3 PUFA continuous presence as a membrane component, it also provides
a persistent tolerance to I/R injury. This persistent preconditioning is also observed with repeated
stresses like exercise and heat exposure [12]. In contrast, early phase IPC did not acutely affect basal
lipid oxidation or antioxidant activity during the 150 min post preconditioning time course of this
study protocol. Moreover, IPC prevention of lipid oxidation and infarction during the index ischaemia
was not additive to the effects of fish oil feeding. Admittedly the anti-infarct effects of both fish oil and
IPC could be individually regarded as already maximal.
Fish oil-induced chronic increases in basal lipid oxidation directly correlated with basal MnSOD
antioxidant activity in myocardium, which in turn was negatively correlated with the I/R-induced
increase in lipid oxidation. This interdependence, which reflects the contrasting damaging influence
and homeostatic signalling roles of ROS in ischaemia and IPC, can explain some of the lack of
consistent correlation between oxidation products and anti-oxidants and sometime failure of oxidation
markers to serve as clear criteria for defining oxidative stress [26]. The effects were consistent on
LPO (an intermediate common to oxidation of all PUFA) and MDA (a stable end product of a single
pathway also not specific for any PUFA family). Ultimately the infarct size was negatively correlated
with MnSOD activity and directly correlated with the increase in lipid oxidation products in the
ISCH region. Chronic elevation of plasma MnSOD has been previously observed during fish oil
feeding [28], consistent with its persistent elevation over several days following multiple exposures to
TNFα, exercise stress or heat stress [12].
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Fish oil induced increases in antioxidant expression and reduced lipid peroxidation products
were also reported in hepatic and renal tissue of immune suppressed mice [29,30] and hepatic tissue of
hypertensive rats [31], conditions associated with heightened oxidative stress. In those studies, the
fish oil diets were effective independently of varied provision of high or low concentrations of natural
antioxidants in comparative n-6 PUFA or MUFA enriched diets. In the current study, the n-6 PUFA rich
diet with its elevated vitamin E content did not change the membrane fatty acid composition sufficiently
to modulate either membrane peroxidisability index or endogenous antioxidant enzyme activity
relative to the low PUFA saturated fat enriched diet, and hearts from those diets were equally highly
susceptible to oxidative damage. This is consistent with previous findings that both membrane effects
and cardioprotective effects of n-6 PUFA are readily lost as the PUFA content is diluted by other fat
sources [32,33]. This is not the case for LCn-3 PUFA, which sustain membrane composition [34,35], and
cardiac [5,10,32,33,36] and other functional effects [35] to very low dietary concentrations. The ability
of low (nutritionally relevant) intakes of fish oil to modify membrane composition and cardiac function,
including prevention of I/R arrhythmias is important, since the provision of extremely high LCn-3
PUFA intakes can be pro-arrhythmic (fish oil concentrate 4 g/d/20 kg dog, equivalent to ě40/d
standard fish oil capsules in an 80 kg man) [37], perhaps representing the harmful effects of excessive
oxidation. Similarly, in a senescence-prone mouse model, high fish oil feeding in conjunction with
high total PUFA enhances oxidative stress and decreases lifespan [38].
The present study suggests that LCn-3 PUFA exert protection from ischaemia by activating
signalling pathways that resemble those involved in late IPC or exercise, and we describe this as
“nutritional preconditioning”. The current study used a LCn-3 PUFA intake equivalent to more than
30 g of fish oil per day in humans [34]. However, even very low doses in the range 0.16%–1.25% FO
markedly increase myocardial DHA and peroxidation index (at 0.31% dietary fish oil equivalent to
human 1–2 fish meals per week) DHA is increased from 7.7% to 14.9% of phospholipid fatty acids
and PI is increased from 149 to 164 (calculated from Slee [34]). This is a dose that modulates skeletal
muscle membrane fatty acids and muscle fatigue [35]. In skeletal muscle, reactive oxygen species
capable of causing cellular damage when in physiological excess can at lower levels also act to optimise
contractile performance and initiate long-term protective adaptations to the intermittent stress imposed
by exercise training [39].
The present study deliberately used a high DHA fish oil, which does not reflect the composition
of most nutritional supplement fish oils, but rather reflects the main LCn-3 PUFA derived from eating
fish [4,40]. As the most abundant n-3 PUFA found in myocardium, DHA is also the main fatty acid
underpinning the cardiac effects of fish and fish oil [4]. The use of two diets for comparison with
fish oil allows specific attribution of the effects of fish oil feeding to its LCn-3 PUFA content, since
similar total PUFA content was provided in the n-6 and LCn-3 PUFA diets; similar n-6 PUFA was
provided in the SF and LCn-3 PUFA diets; and low saturated fat was provided in the n-6 PUFA diet,
all without effect.
The increased expression of antioxidants within LCn-3 PUFA hearts was restricted to the
mitochondrial form of SOD (MnSOD or SOD2) with CuZnSOD and GSx unchanged. This suggests
localisation of the primarily influence of LCn-3 PUFA to the mitochondria. Increased MnSOD
activity is similarly selectively implicated in the sustained cardioprotection elicited by heat stress
and in late, delayed or second window of IPC [41], whereas over-expression of cardiac MnSOD
in mice enhances contractile function, slows heart rate and increases efficiency of myocardial O2
consumption [42], all properties shared by dietary fish oil [5,43,44]. Furthermore, the fish oil-reduced
cardiac oxygen consumption and reduced susceptibility to I/R-damage and arrhythmias in rats is
linked to mitochondrial Ca2+ handling [44]. In contrast, early IPC inhibited acute lipid oxidation
and infarction did not involve upregulation of mitochondrial SOD, confirming its difference from
late IPC [41] and highlighting a difference to the more persistent forms of preconditioning including
exercise [45–47], late IPC [41] and now fish oil-induced nutritional preconditioning.
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This study confirmed that increasing myocardial membrane percentage content of long chain
n-3 highly polyunsaturated fatty acids by feeding fish oil, increased the basal peroxidation of cellular
fatty acids, which in turn increased the activity of endogenous mitochondrial antioxidant superoxide
dismutase. When these hearts were acutely subjected to regional I/R, the stimulated lipid oxidation
and myocardial damage were reduced. The increase in peroxidation index of myocardial membranes
through fatty acid compositional change and associated chronic mild elevation in lipid peroxidation
products provokes a persistent physiological stress that might better be described as “oxidative
shielding” [48], which if confirmed at lower fish oil intakes, could explain much of the cardioprotective
effect of regular fish consumption. This readily available and safe nutritional approach appears to
represent a natural form of late preconditioning, which, characterised by its persistence over time,
would be particularly valuable in the clinical setting, where oxidative insults occur unexpectedly and
preclude the use of planned preventative interventions [41]. The observation, however, also raises the
possibility that like exercise training [45], effects of fish oil nutritional preconditioning may be blunted
by concomitant antioxidant supplementation.
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